Stryker Co. (NYSE:SYK) Shares Bought by Heritage Wealth Management Inc. CA

Heritage Wealth Management Inc. CA raised its stake in shares of Stryker Co. (NYSE:SYK) by 4,802.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,451 shares of the medical technology company’s stock after purchasing an additional 2,401 shares during the quarter. Heritage Wealth Management Inc. CA’s holdings in Stryker were worth $883,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in SYK. Zions Bancorporation N.A. increased its position in shares of Stryker by 21.3% in the 4th quarter. Zions Bancorporation N.A. now owns 16,526 shares of the medical technology company’s stock valued at $5,950,000 after acquiring an additional 2,907 shares during the period. Ashton Thomas Securities LLC increased its holdings in shares of Stryker by 3.9% in the fourth quarter. Ashton Thomas Securities LLC now owns 1,203 shares of the medical technology company’s stock valued at $434,000 after purchasing an additional 45 shares during the period. TD Asset Management Inc. raised its stake in shares of Stryker by 7.0% in the fourth quarter. TD Asset Management Inc. now owns 1,264,686 shares of the medical technology company’s stock worth $455,350,000 after purchasing an additional 82,306 shares during the last quarter. Modern Wealth Management LLC lifted its holdings in shares of Stryker by 197.6% during the fourth quarter. Modern Wealth Management LLC now owns 2,845 shares of the medical technology company’s stock worth $1,117,000 after purchasing an additional 1,889 shares during the period. Finally, CoreFirst Bank & Trust acquired a new position in Stryker in the 4th quarter worth approximately $245,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Stryker

In other Stryker news, Director Allan C. Golston sold 2,458 shares of the firm’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the transaction, the director now owns 14,895 shares in the company, valued at approximately $5,705,827.65. This trade represents a 14.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Ronda E. Stryker sold 201,392 shares of the company’s stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the sale, the director now directly owns 3,642,075 shares of the company’s stock, valued at $1,428,567,498. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 5.90% of the company’s stock.

Stryker Stock Performance

NYSE:SYK opened at $374.43 on Tuesday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95. The stock has a market capitalization of $142.87 billion, a PE ratio of 48.25, a P/E/G ratio of 2.93 and a beta of 0.95. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The company has a fifty day moving average of $384.55 and a two-hundred day moving average of $374.24.

Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter in the prior year, the firm posted $3.46 earnings per share. As a group, research analysts forecast that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a $0.84 dividend. The ex-dividend date is Monday, March 31st. This represents a $3.36 annualized dividend and a dividend yield of 0.90%. Stryker’s dividend payout ratio (DPR) is presently 43.30%.

Analysts Set New Price Targets

Several analysts have commented on SYK shares. JPMorgan Chase & Co. lifted their price objective on shares of Stryker from $420.00 to $445.00 and gave the company an “overweight” rating in a research note on Wednesday, January 29th. Truist Financial boosted their target price on shares of Stryker from $409.00 to $413.00 and gave the company a “hold” rating in a research report on Thursday, January 30th. Citigroup reaffirmed a “buy” rating and set a $450.00 price target on shares of Stryker in a research report on Wednesday, February 26th. The Goldman Sachs Group set a $422.00 price objective on Stryker in a report on Tuesday, March 4th. Finally, Argus set a $450.00 target price on Stryker in a report on Monday, February 3rd. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $421.90.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.